India’s leading diabetes chain of hospitals - Dr. Mohan’s Diabetes Specialities Centre, in collaboration with its research wing Madras Diabetes Research Foundation, has announced the launch of the first-of-its-kind novel ‘Diabetes Liver Clinic’, a Centre of Excellence dedicated to the research, prevention and management of liver complications in individuals with diabetes.

Recent research spotlights the less-appreciated association between diabetes and liver health, as the liver plays a critical role being a glucose storehouse and its susceptibility to conditions such as 'Fatty Liver' has recently come into focus.

Dr. V. Mohan's research underscores that over 50% of individuals with type 2 diabetes experience some degree of fatty liver. This sets the stage for 'Hepatic Insulin Resistance,' where insulin function in the liver diminishes, leading to elevated glucose release, particularly during fasting, emphasising the interplay between fatty liver and type 2 diabetes.

The evolving understanding of this bidirectional relationship highlights the importance of addressing these conditions holistically, marking a shift from a glucose-centric diabetes treatment approach to a broader metabolic care framework, where the liver plays a central role.

In lieu of this, Dr. Mohan’s Diabetes Specialities Centre and the Madras Diabetes Research Foundation have introduced the revolutionary novel Diabetes Liver Clinic marking a significant shift in the approach to diabetes care.

Topping the list of priorities, the clinic will mainly focus on providing population-based normative data on novel liver function markers in both men and women across different age groups in India.